Ultraearly repeated systemic thrombolysis in recurrent ischemic stroke – A multicentre case study

We analysed outcomes of patients who received off-label repeated thrombolysis with recombinant tissue plasminogen activator for ischemic stroke recurrence within 10  days (ultraearly repeated thrombolysis, UERT).

Source: Journal of the Neurological Sciences - June 14, 2023 Category: Neurology Authors: Thorleif Etgen, Manuel Cappellari, David Černík, Raffi Topakian, Luciano A. Sposato, Philippe Sardag, Hanni Wiestler Source Type: research